ALG889: Began Phase I trial

Allergene Inc., San Mateo, Calif.
Product: ALG889
Business: Infectious diseases
Therapeutic

Read the full 112 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE